These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29717168)

  • 21. Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists.
    Zhu Y; Zhang J; Min F; Yang X; Li L; Zhang Y; Hou X; Fang H
    Bioorg Med Chem Lett; 2022 Nov; 76():128993. PubMed ID: 36130662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound.
    Lamers C; Merk D; Gabler M; Flesch D; Kaiser A; Schubert-Zsilavecz M
    Future Med Chem; 2016; 8(2):133-48. PubMed ID: 26824277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity.
    Sepe V; Renga B; Festa C; Finamore C; Masullo D; Carino A; Cipriani S; Distrutti E; Fiorucci S; Zampella A
    Steroids; 2016 Jan; 105():59-67. PubMed ID: 26607331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
    Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
    Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress and challenges of selective Farnesoid X Receptor modulation.
    Massafra V; Pellicciari R; Gioiello A; van Mil SWC
    Pharmacol Ther; 2018 Nov; 191():162-177. PubMed ID: 29933033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.
    Fujino T; Murakami K; Ozawa I; Minegishi Y; Kashimura R; Akita T; Saitou S; Atsumi T; Sato T; Ando K; Hara S; Kikugawa K; Hayakawa M
    FEBS J; 2009 Mar; 276(5):1319-32. PubMed ID: 19187229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile acid derivatives as ligands of the farnesoid x receptor: molecular determinants for bile acid binding and receptor modulation.
    Gioiello A; Cerra B; Mostarda S; Guercini C; Pellicciari R; Macchiarulo A
    Curr Top Med Chem; 2014; 14(19):2159-74. PubMed ID: 25388535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FXR: a promising target for the metabolic syndrome?
    Cariou B; Staels B
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.
    Deng R; Yang D; Radke A; Yang J; Yan B
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
    Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
    Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.
    Carter BA; Taylor OA; Prendergast DR; Zimmerman TL; Von Furstenberg R; Moore DD; Karpen SJ
    Pediatr Res; 2007 Sep; 62(3):301-6. PubMed ID: 17622954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
    Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
    J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oleanolic acid is a selective farnesoid X receptor modulator.
    Liu W; Wong C
    Phytother Res; 2010 Mar; 24(3):369-73. PubMed ID: 19653193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.